Role of Imaging in Prostate Cancer.
作者信息
Jadvar Hossein, Alavi Abass
出版信息
PET Clin. 2009 Apr 1;4(2):135-8. doi: 10.1016/j.cpet.2009.05.003.
Abstract
摘要
相似文献
1
Role of Imaging in Prostate Cancer.影像学在前列腺癌中的作用。
PET Clin. 2009 Apr 1;4(2):135-8. doi: 10.1016/j.cpet.2009.05.003.
2
Role of multi-parametric (mp) MRI in prostate cancer.多参数磁共振成像（mpMRI）在前列腺癌中的作用。
J Pak Med Assoc. 2018 Jan;68(1):98-104.
3
Multiparametric-MRI in diagnosis of prostate cancer.多参数磁共振成像在前列腺癌诊断中的应用
Indian J Urol. 2015 Jul-Sep;31(3):194-201. doi: 10.4103/0970-1591.159606.
4
Current role of multiparametric magnetic resonance imaging for prostate cancer.多参数磁共振成像在前列腺癌中的当前作用
Quant Imaging Med Surg. 2015 Oct;5(5):754-64. doi: 10.3978/j.issn.2223-4292.2015.10.08.
5
Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging.主动监测管理的前列腺癌：解剖磁共振成像和磁共振波谱成像的作用。
Radiology. 2010 Jul;256(1):176-83. doi: 10.1148/radiol.10091147. Epub 2010 May 26.
6
Incorporating imaging into personalized medicine for the detection of prostate cancer: Pharmacological research-Urogenital pharmacology.将成像技术纳入个性化医疗以检测前列腺癌：药理学研究——泌尿生殖药理学。
Pharmacol Res. 2016 Dec;114:163-165. doi: 10.1016/j.phrs.2016.10.020. Epub 2016 Oct 21.
7
Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer.多参数前列腺磁共振成像在前列腺癌评估中的应用
CA Cancer J Clin. 2016 Jul;66(4):326-36. doi: 10.3322/caac.21333. Epub 2015 Nov 23.
8
Multiparametric magnetic resonance imaging: Current role in prostate cancer management.多参数磁共振成像：在前列腺癌管理中的当前作用。
Int J Urol. 2016 Jul;23(7):550-7. doi: 10.1111/iju.13119. Epub 2016 May 17.
9
Exploring the role of multimodal [F]F-PSMA-1007 PET/CT and multiparametric MRI data in predicting ISUP grading of primary prostate cancer.探索多模态[F]F-PSMA-1007 PET/CT和多参数MRI数据在预测原发性前列腺癌ISUP分级中的作用。
Eur J Nucl Med Mol Imaging. 2025 May;52(6):2087-2095. doi: 10.1007/s00259-025-07099-0. Epub 2025 Jan 28.
10
A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.一项评价磁共振成像在普通人群中前列腺癌筛查作用的初步研究。
J Urol. 2016 Aug;196(2):361-6. doi: 10.1016/j.juro.2016.01.114. Epub 2016 Feb 13.
引用本文的文献
1
The diagnostic value of whole-body HYNIC-PSMA 11 -Tc [Tc] SPECT/CT scan in early staging of patients with moderate- and high-risk prostate cancer.全身HYNIC-PSMA 11 -Tc[Tc]SPECT/CT扫描在中高危前列腺癌患者早期分期中的诊断价值
Ann Nucl Med. 2025 May 10. doi: 10.1007/s12149-025-02055-2.
2
Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer.谷氨酰胺利用的代谢差异导致前列腺癌的代谢脆弱性。
Sci Rep. 2017 Nov 23;7(1):16159. doi: 10.1038/s41598-017-16327-z.
3
Influence of (11)C-choline PET/CT on radiotherapy planning in prostate cancer.（11）C-胆碱PET/CT对前列腺癌放射治疗计划的影响
Rep Pract Oncol Radiother. 2014 Dec 16;20(2):104-12. doi: 10.1016/j.rpor.2014.11.008. eCollection 2015 Mar-Apr.
4
Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake.通过抗1-氨基-2-[(18)F]-氟环丁烷-1-羧酸（抗3-[(18)F]FACBC）摄取对原发性前列腺癌进行表征。
Am J Nucl Med Mol Imaging. 2013;3(1):85-96. Epub 2013 Jan 5.
5
Role of ¹¹C-choline positron emission tomography/computed tomography in evaluating patients affected by prostate cancer with suspected relapse due to prostate-specific antigen elevation.¹¹C-胆碱正电子发射断层扫描/计算机断层扫描在评估因前列腺特异性抗原升高而怀疑复发的前列腺癌患者中的作用。
Jpn J Radiol. 2011 Jul;29(6):394-404. doi: 10.1007/s11604-011-0570-1. Epub 2011 Jul 24.
6
Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.前列腺癌：18F-FDG、18F-或 11C-乙酸盐、18F-或 11C-胆碱的 PET 成像。
J Nucl Med. 2011 Jan;52(1):81-9. doi: 10.2967/jnumed.110.077941. Epub 2010 Dec 13.
本文引用的文献
1
Bone imaging in prostate cancer.前列腺癌的骨显像
Nat Clin Pract Urol. 2008 Aug;5(8):434-44. doi: 10.1038/ncpuro1190.
2
Prostate cancer imaging.前列腺癌成像。
Acta Radiol. 2008 Feb;49(1):107-20. doi: 10.1080/02841850701545821.
3
Imaging of prostate cancer.前列腺癌的影像学检查
Curr Opin Oncol. 2007 May;19(3):259-64. doi: 10.1097/CCO.0b013e3280ad439b.
4
Imaging for prostate cancer.
Clin Oncol (R Coll Radiol). 2005 Oct;17(7):553-9. doi: 10.1016/j.clon.2005.07.003.
5
Advances in imaging in the postoperative patient with a rising prostate-specific antigen level.前列腺特异性抗原水平升高的术后患者的影像学进展。
Semin Oncol. 2003 Oct;30(5):616-34. doi: 10.1016/s0093-7754(03)00359-2.
6
Quantitative evaluation of bone metastases in patients with advanced prostate cancer during systemic treatment.
BJU Int. 2003 Sep;92(4):379-83; discussion 383-4. doi: 10.1046/j.1464-410x.2003.04362.x.
7
Metastatic prostate cancer: complications and treatment.转移性前列腺癌：并发症与治疗
J Am Geriatr Soc. 2003 Aug;51(8):1136-42. doi: 10.1046/j.1532-5415.2003.51367.x.
8
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.前列腺癌临床隐匿性淋巴结转移的非侵入性检测
N Engl J Med. 2003 Jun 19;348(25):2491-9. doi: 10.1056/NEJMoa022749.
9
The natural history of prostate cancer.
Urol Clin North Am. 2003 May;30(2):219-26. doi: 10.1016/s0094-0143(02)00182-9.
10
Therapeutic targets for metastatic prostate cancer.转移性前列腺癌的治疗靶点。
Curr Drug Targets. 2003 Apr;4(3):251-61. doi: 10.2174/1389450033491127.
Zotero 插件